Eureka AI Results Explorer
Unified interface for interacting with AI algorithm outputs from multiple sources
Company profile
Company profile
TeraRecon is a leading provider of AI-powered advanced medical imaging and visualization solutions for healthcare organizations. The company specializes in delivering enterprise imaging decision support across radiology, cardiology, neurology, and other clinical specialties. TeraRecon's flagship platforms include TeraRecon AV (registered as Intuition in global markets), a SaaS-based advanced medical imaging solution with AI-driven automations that enhance diagnostic precision and efficiency, and TeraRecon DETECT, which helps healthcare providers drive adoption of reimbursable AI biomarkers across their entire imaging enterprise. The company's solutions integrate cutting-edge artificial intelligence with physician insights to improve time-to-treatment and patient outcomes. TeraRecon's platform consolidates multiple 3D and AI solutions into one powerful, subscription-based system, enabling healthcare organizations to minimize costs while scaling capabilities. The company partners with numerous AI algorithm developers and PACS vendors to deliver seamless end-to-end imaging solutions. TeraRecon serves health systems, hospitals, and imaging centers globally, providing consistent imaging decision support that extends from the reading room to the surgical suite and point of care. Their solutions are designed to accelerate clinical workflows, increase throughput, and save physician and technologist time while maintaining diagnostic accuracy.
Company description TeraRecon official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas · Other deployment with recorded integration context.
Recorded integration context: AGFA HealthCare, Ambra Health, Change Healthcare, Esaote, Exprivia, INFINITT PACS, Intelerad, Merge by Merative, Pixeon Aurora, Sectra.
Company milestones
Introduction of next generation imaging solutions under ConcertAI; TeraRecon AV registered as Intuition in global markets; expansion of AI partner ecosystem with multiple algorithm integrations
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Unified interface for interacting with AI algorithm outputs from multiple sources
Premium support and success program for TeraRecon customers
SaaS-based advanced medical imaging with AI-driven automations for enhanced diagnostic precision
AI biomarker platform driving adoption of reimbursable AI across imaging enterprises
Advanced medical imaging visualization platform (global market name for TeraRecon AV)
AI-powered neurological imaging solution suite
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Journal of hypertension · Nov 1, 2021
Patient Perceptions and Knowledge of Ionizing Radiation From Medical Imaging.JAMA network open · Oct 1, 2021
Quantitative imaging and automated fuel pin identification for passive gamma emission tomography.Scientific reports · Jan 28, 2021
Patient Based Bull's Eye Map Display of Coronary Artery and Ventricles From Coronary Computed Tomography Angiography.Journal of computer assisted tomography · Jan 1, 2020
Estimation of Diastolic Filling Pressure with Cardiac CT in Comparison with Echocardiography Using Tissue Doppler Imaging: Determination of Optimal CT Reconstruction Parameters.Korean journal of radiology · Jan 1, 2017
Between-Scanner and Between-Visit Variation in Normal White Matter Apparent Diffusion Coefficient Values in the Setting of a Multi-Center Clinical Trial.Clinical neuroradiology · Dec 1, 2016
Clinical validation
No linked records are currently available.
Regulatory
K250288 · 510k · Oct 23, 2025
TeraRecon Aorta.CT (1.1.0)K243158 · 510k · Jan 23, 2025
TeraRecon Cardiac.Chambers.MR (1.0.0)K241312 · 510k · Nov 5, 2024
TeraRecon NeuroK220349 · 510k · Aug 12, 2022
Neuro.Al AlgorithmK200750 · 510k · Nov 6, 2020
iNtuition-Structural Heart ModuleK191585 · 510k · Jul 12, 2019
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Through AI-driven workflow automation
AI-enhanced visualization and detection
Bone suppression technology and automated analysis
Workflow acceleration with AI efficiency gains
Bone suppression technology for chest radiographs
Bone Suppression technology for chest radiographs in lung screening program
Faster and more confident diagnosis without additional time or risk to patients
Advanced visualization for cardiothoracic radiology with focus on ease of use and interface design
Improved workflow efficiency through superior user interface
Unified AI algorithm integration through Eureka AI Results Explorer
Simplified workflow with consistent interface for multiple AI algorithms
05 · Leadership
Leadership profiles and professional links from the current Company record.
Michael Winkler
Professor of Radiology, Division of Cardiothoracic Radiology
Jared Christensen
Assistant Professor of Radiology, Division Chief of Cardiothoracic Imaging, Director of Duke Lung Screening Program
Matt Dewey
Chief Information Officer
Andrew Duckworth
VP of Business Development
06 · Company updates
Recent articles published on TeraRecon's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.